Join our Live Webcast on Monday, December 2 at 11:00AM EST.
About the Weinberg Group
Our Mission and Values
Meet Our Team
News and Events
PROPHARMA GROUP SITE
The World’s Leading FDA Consultants.
DRUGS & BIOTECH
Regulatory Strategy Consulting
End of Phase 2 Meeting
FDA Advisory Committee Meeting
NDA Submissions: 505(b)(1) & 505(b)(2)
Orphan Drug Designation
Nonclinical Drug Development
Study Design, Placement, & Monitoring
Discovery Stage Assistance
Results Analysis & Design of Follow On Work
Regulatory Due Diligence
QUALITY & COMPLIANCE
Good Clinical Practice (GCP) Services
Good Manufacturing Practices (GMP) Services
Quality Systems & Quality Management
Ready to get started? Have questions?
You can complete the form to get started or contact us at our office.
1129 Twentieth Street NW
Washington, DC 20036